Literature DB >> 16380133

Mutation analysis of the ATM gene in two Chinese patients with ataxia telangiectasia.

Hong Jiang1, Beisha Tang, Kun Xia, Zhengmao Hu, Lu Shen, Jianguang Tang, Guohua Zhao, Yuhu Zhang, Fang Cai, Qian Pan, Zhigao Long, Guo Wang, Heping Dai.   

Abstract

Ataxia telangiectasia (A-T) is an autosomal recessive disorder characterized by cerebellar ataxia, telangiectasia, immunodeficiency, elevated alpha-fetoprotein level, chromosomal instability, predisposition to cancer, and radiation sensitivity. Although a lot of mutations in the ATM gene have been described, there is still no report about ATM mutations in Chinese population. Using a molecular approach, we screened for ATM mutations in two patients from two unrelated Chinese families. 100 normal controls were analyzed to exclude possibility of polymorphism. Two novel mutations in the ATM gene were identified. The first one is a novel, homozygous, 1346G>C (Gly449Ala) missense mutation. The second one is a compound heterozygous mutation, which consists of a novel, 610G>T (Gly204Stop) nonsense mutation, combined with a previously reported, 6679C>T (Arg2227Cys) missense mutation. The transversions 1346G>C (Gly449Ala) and 610G>T (Gly204Stop) are not localized either in the conserved PI-3 kinase domain or in the other domains of the ATM protein. The phenotypic features were characterized by progressive cerebellar ataxia, ocular telangiectasia, elevated alpha-fetoprotein level, immunodeficiency (agammaglo-bulinemia and T-cell defect), and rearrangements of chromosomes 7 and 14; brain MRI showed cerebellar atrophy, brain SPECT showed cerebellar regional cerebral blood flow (rCBF) hypoperfusion. To our knowledge, this is the first report of ATM mutations in Mainland China, in which the transversions 1346G>C (Gly449Ala) and 610G>T (Gly204Stop) are two novel, disease-causing mutations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16380133     DOI: 10.1016/j.jns.2005.09.001

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Brain glucose metabolism in adults with ataxia-telangiectasia and their asymptomatic relatives.

Authors:  Nora D Volkow; Dardo Tomasi; Gene-Jack Wang; Yana Studentsova; Brad Margus; Thomas O Crawford
Journal:  Brain       Date:  2014-04-17       Impact factor: 13.501

2.  Identification of ATM mutations in Korean siblings with ataxia-telangiectasia.

Authors:  Hee Jae Huh; Kyoo-Ho Cho; Ji Eun Lee; Min-Jung Kwon; Chang-Seok Ki; Phil Hyu Lee
Journal:  Ann Lab Med       Date:  2013-04-17       Impact factor: 3.464

3.  Targeted Next-Generation Sequencing Revealed Novel Mutations in Chinese Ataxia Telangiectasia Patients: A Precision Medicine Perspective.

Authors:  Zhao Chen; Wei Ye; Zhe Long; Dongxue Ding; Huirong Peng; Xuan Hou; Rong Qiu; Kun Xia; Beisha Tang; Hong Jiang
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

4.  Twelve novel Atm mutations identified in Chinese ataxia telangiectasia patients.

Authors:  Yu Huang; Lu Yang; Jianchun Wang; Fan Yang; Ying Xiao; Rongjun Xia; Xianhou Yuan; Mingshan Yan
Journal:  Neuromolecular Med       Date:  2013-06-27       Impact factor: 3.843

5.  The natural history of ataxia-telangiectasia (A-T): A systematic review.

Authors:  Emily Petley; Alexander Yule; Shaun Alexander; Shalini Ojha; William P Whitehouse
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.752

6.  Ataxia-telangiectasia with novel splicing mutations in the ATM gene.

Authors:  Heejeong Jeong; Hee Jae Huh; Jinyoung Youn; Ji Sun Kim; Jin Whan Cho; Chang-Seok Ki
Journal:  Ann Lab Med       Date:  2013-12-06       Impact factor: 3.464

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.